[Evaluation of lisinopril and lisinopril-hydrochlorothiazide combination in mild to moderate arterial hypertension].

Abstract

The main objective of this multicenter study was to compare the efficacy of an increase in dose and of a synergic combination in the 68 patients out of 126 (54%) with hypertension (DBP between 95 and 120 mm Hg after 2 weeks of placebo) who did not respond (DBP > or = 95 mmHg) to a 4-week treatment of 20 mg per day of lisinopril. Patients were randomized to receive a 4-week double-blind treatment of either 40 mg per day of lisinopril or the combination of 20 mg of lisinopril and 12.5 mg of hydrochlorothiazide per day. Mean reductions of systolic (inter-group comparison: p = 0.08) and diastolic BP (p = 0.006) as well as the proportion of responders (82% versus 45%, p < or = 0.01) were greater with the lisinopril-hydrochlorothiazide combination than with 40 mg of lisinopril. Tolerance was good in the 3 groups. The administration of a synergic combination is justified when hypertension is not controlled by a monotherapy.

• Authors: J J Leduc, O Madonna, V Gressin
• Journal: Therapie (Therapie) 1994 Jan-Feb Vol. 49 Issue 1 Pg. 17-22 ISSN: 0040-5957 [Print] France
• Vernacular Title: Evaluation du lisinopril et de l'association lisinopril-hydrochlorothiazide dans l'hypertension artérielle légère à modérée. Groupe de Travail Prinzide.
• PMID: 8091360 (Publication Type: Clinical Trial, English Abstract, Journal Article, Multicenter Study, Randomized Controlled Trial)

Chemical References

• Hydrochlorothiazide
• Lisinopril

Topics

• Dose-Response Relationship, Drug
• Double-Blind Method
• Drug Synergism
• Drug Therapy, Combination
• Humans
• Hydrochlorothiazide (administration & dosage, therapeutic use)
• Hypertension (drug therapy, physiopathology)
• Lisinopril (administration & dosage, therapeutic use)